CIK 0001072379 · Non-accelerated filer<br>Smaller reporting company
NORTHWEST BIOTHERAPEUTICS INC
Sign in to watch- Ticker
- NWBO
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943306718
- Phone
- (240) 497-9024
- Business address
- 4800 MONTGOMERY LANE, SUITE 800, BETHESDA, MD, 20814
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2009-11-07 | BOYNTON ALTON L Chief Executive Officer | Grant or award · Convertible Note | +419,270 | $0.20 | $84K | 2,380,393 |
| 2009-11-07 | BOYNTON ALTON L Chief Executive Officer | Conversion · Convertible Note | −419,270 | $0.20 | $84K | 2,380,293 |
| 2009-10-14 | BOYNTON ALTON L Chief Executive Officer | Gift | −150,083 | 1,961,123 | ||
| 2009-09-30 | Cognate Bioservices, Inc. 10% owner | Grant or award | +750,000 | $0.20 | $150K | 3,322,710 |
| 2009-09-30 | Cognate Bioservices, Inc. 10% owner | Purchase | +1,762,500 | $0.20 | $353K | 10,309,780 |
| 2009-09-28 | Cognate Bioservices, Inc. 10% owner | Other acquisition | +5,783,589 | $0.20 | $1.2M | 5,783,589 |
| 2009-09-28 | Cognate Bioservices, Inc. 10% owner | Other acquisition | +2,763,691 | $0.20 | $553K | 8,547,280 |
| 2009-09-28 | Cognate Bioservices, Inc. 10% owner | Other acquisition · Warrants | +690,000 | 690,000 | ||
| 2009-09-28 | Cognate Bioservices, Inc. 10% owner | Other acquisition · Warrants | +152,375 | 842,375 | ||
| 2009-09-28 | Cognate Bioservices, Inc. 10% owner | Other acquisition · Warrants | +513,841 | 1,356,216 | ||
| 2009-08-21 | BOYNTON ALTON L President and CEO | Grant or award · Option | +1,430,486 | 2,830,016 | ||
| 2009-08-21 | BOYNTON ALTON L President and CEO | Grant or award · Option | +1,430,486 | 2,830,016 | ||
| 2009-06-30 | Cognate Bioservices, Inc. 10% owner | Purchase · 6% Convertible Promissory Notes | +0 | $1,300,000.00 | $0 | |
| 2009-01-01 | BOYNTON ALTON L President and CEO | Returned to the company · Option | −1,430,486 | 1,399,530 | ||
| 2008-12-22 | Cognate Bioservices, Inc. 10% owner | Purchase · Warrants | +132,500 | 132,500 | ||
| 2008-08-19 | Powers Linda F Director | Purchase · Promissory Note | +0 | |||
| 2007-12-31 | BOYNTON ALTON L President & CEO | Grant or award · Option | +2,807,048 | $0.60 | $1.7M | 2,830,016 |
| 2007-10-01 | DEASEY ANTHONY P Senior VP of Finance - CFO | Grant or award · Stock Option | +769,208 | $2.40 | $1.8M | 769,208 |
| 2007-06-22 | Toucan Capital Fund II, LP 10% owner | Conversion | +2,166,667 | 2,166,667 | ||
| 2007-06-22 | Toucan Capital Fund II, LP 10% owner | Conversion | +12,844,968 | 15,011,635 |
Page 13 of 19 · 374 trades